HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website – founded as a partnership between CHDI and the Coppola Lab at UCLA – is currently a joint development effort by CHDI, Bridlewood Consulting and Rancho BioSciences. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
| Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool. |
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
HDBuzz
- HD2026 Milton Wexler Biennial Symposium Day 3
- HD2026 Milton Wexler Biennial Symposium Day 2
- HD2026 Milton Wexler Biennial Symposium Day 1
- Prilenia shares HD trial data with CHDI to help future research
- Looking back and moving forward: Questions and lessons 4 weeks out from Roche’s disappointing news
Literature
- Blocking somatic repeat expansion and lowering huntingtin by RNAi synergize to attenuate Huntington's disease pathogenesis in mice
- In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging
- Cholesterol nose-to-brain delivery as a possible therapeutic strategy in Huntington's disease
- Molecular insights of peroxisome proliferator-activated receptor-gamma signalling in amyotrophic lateral sclerosis and Huntington's disease
- USP28 Deficiency is Linked to Impaired Ubiquitin-dependent Proteostasis in Huntington's Disease
News
- HD2026 Milton Wexler Biennial Symposium Day 3 - HDBuzz
- Rhelion Life Sciences Signs Agreement with University Health Network for Randomized ...
- Latest news about uniQure N.V. - MarketScreener
- Cork TDs demand approval for life-changing drug Skyclarys after HSE decision
- The Swedish Brain Foundation invests in brainpower in Umeå




